ORMP - Oramed Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ORMP is currently covered by 1 analysts with an average price target of $11.6. This is a potential upside of $9.34 (413.27%) from yesterday's end of day stock price of $2.26.

Oramed Pharmaceuticals's activity chart (see below) currently has 13 price targets and 17 ratings on display. The stock rating distribution of ORMP is 100% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 58.75% with an average time for these price targets to be met of 125.75 days.

Highest price target for ORMP is $2, Lowest price target is $2.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 09-Sep-2024. First documented stock forecast 04-Dec-2013.

Best performing analysts who are covering ORMP - Oramed Pharmaceuticals:

Raghuram Selvaraju Edward Nash Nathan Weinstein Jim Molloy

Currently out of the existing stock ratings of ORMP, 2 are a HOLD (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

8 months 25 days ago
(09-Sep-2024)

3/5 (60%)

$18.28 (133.24%)

278

Hold

$2

$-0.34 (-14.53%)

$3

2 years 17 days ago
(17-May-2023)

3/4 (75%)

$-1.63 (-44.90%)

157

Buy

$35

3 years 18 days ago
(16-May-2022)

1/2 (50%)

$9.92 (39.55%)

62

Buy

$40

$37.78 (1701.80%)

$11

3 years 6 months 25 days ago
(09-Nov-2021)

1/2 (50%)

$10.78 (36.89%)

6

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ORMP (Oramed Pharmaceuticals) average time for price targets to be met?

On average it took 125.75 days on average for the stock forecasts to be realized with a an average price target met ratio 58.75

Which analyst has the current highest performing score on ORMP (Oramed Pharmaceuticals) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the current lower performing score on ORMP (Oramed Pharmaceuticals) with a proven track record?

JIM MOLLOY

Which analyst has the most public recommendations on ORMP (Oramed Pharmaceuticals)?

Raghuram Selvaraju has 3 price targets and 17 ratings on ORMP

Which analyst is the currently most bullish on ORMP (Oramed Pharmaceuticals)?

Jim Molloy with highest potential upside - $37.78

Which analyst is the currently most reserved on ORMP (Oramed Pharmaceuticals)?

Edward Nash with lowest potential downside - -$0.34

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?